BUY Blue Star — Sumeet Bagadia, 11 Sept 2026

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))11 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹1,514Stated

Target₹1,620

Stop loss₹1,461-3.50% risk

CMP₹1,535.3Just now

Active+1.41%+5.52%upside left 14d left

Follow Sumeet Bagadia for new calls(31% target hit, 278 closed calls)Get alerts Watch BLUESTARCO for new buy/sell callsGet alerts See 264 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 11 Sept, 11:35 am IST

1 supporting3 neutral3 opposing

Supports the BUY call (1)

MACD above its signal line — bullish momentum

Technicals · macd·11 Sept · today

Neutral / worth noting (3)

Somerset-backed Cyrix Healthcare acquires Blue Star’s medtech business

NewsGoogle News·7 Sept · 3d ago

Cyrix Healthcare acquires Blue Star E&E's MedTech Solutions business

NewsGoogle News·5 Sept · 5d ago

Cyrix Healthcare acquires Blue Star E&E’s MedTech business

NewsGoogle News·4 Sept · 6d ago

Weighs against the BUY call (3)

Blue Star sees no Q2 margin recovery as raw material costs bite

NewsGoogle News·8 Sept · 3d ago

Blue Star Share Price Falls 2.33%: Technicals, Valuation

NewsGoogle News·8 Sept · 3d ago

Blue Star Reports Ongoing Q2 Challenges Amid Input Price Inflation

NewsGoogle News·8 Sept · 3d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Blue Star — Sumeet Bagadia, Choice Broking

AI Assessment